Literature DB >> 5158270

Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study.

A Z Bluming, J L Ziegler, L Fass, R B Herberman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5158270      PMCID： PMC1713125     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  15 in total

1.  Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

Authors:  L J Old; E A Boyse; H F Oettgen; E D Harven; G Geering; B Williamson; P Clifford
Journal:  Proc Natl Acad Sci U S A       Date:  1966-12       Impact factor: 11.205

2.  The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

Authors:  P Alexander; J Bensted; E J Delorme; J G Hall; J Hodgett
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-11-18

3.  EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence.

Authors:  G Klein; P Clifford; G Henle; W Henle; G Geering; L J Old
Journal:  Int J Cancer       Date:  1969-07-15       Impact factor: 7.396

4.  Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.

Authors:  G Henle; W Henle; P Clifford; V Diehl; G W Kafuko; B G Kirya; G Klein; R H Morrow; G M Munube; P Pike; P M Tukei; J L Ziegler
Journal:  J Natl Cancer Inst       Date:  1969-11       Impact factor: 13.506

5.  Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.

Authors:  I Hellström; K E Hellström
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

6.  Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomas.

Authors:  I Hellström; C A Evans; K E Hellström
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

7.  Studies on serum-mediated inhibition of cellular immunity to spontaneous mouse mammary tumors.

Authors:  G H Heppner
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

8.  Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells.

Authors:  L Fass; R B Herberman; J Ziegler
Journal:  N Engl J Med       Date:  1970-04-02       Impact factor: 91.245

9.  Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction.

Authors:  G Klein; P Clifford; E Klein; J Stjernswärd
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

10.  Evidence for anti-Burkitt tumour globulins in Burkitt tumour patients and healthy individuals.

Authors:  B O Osunkoya
Journal:  Br J Cancer       Date:  1967-06       Impact factor: 7.640
View more
  4 in total

1.  Infectious diseases and immunological responses in adult subjects with lifetime untreated, congenital GH deficiency.

Authors:  Viviane C Campos; Mônica R Barrios; Roberto Salvatori; Roque Pacheco de Almeida; Enaldo V de Melo; Ana C S Nascimento; Amélia Ribeiro de Jesus; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2016-08-03       Impact factor: 3.633

2.  Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.

Authors:  I T Magrath; J L Ziegler
Journal:  Br Med J       Date:  1976-03-13

3.  Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity.

Authors:  S K Sundar; J Bergeron; J Menezes
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

4.  Response of cows with lymphoma to the intradermal injection of tumor cell antigens and phytohemagglutinin.

Authors:  R M Jacobs; V E Valli; B N Wilkie
Journal:  Can J Comp Med       Date:  1981-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.